Related Experiment Video
Updated: May 13, 2026
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
[Farewell to the intra-aortic balloon pump?]
José P S Henriques1, Bas A J M de Mol
1Academisch Medisch Centrum, AMC Hartcentrum, Amsterdam, the Netherlands. j.p.henriques@amc.uva.nl
Nederlands Tijdschrift Voor Geneeskunde
|March 15, 2013
Summary
The intra-aortic balloon pump (IABP), used for decades in cardiac care, is becoming obsolete due to recent trial failures. Future cardiac devices require rigorous testing before widespread clinical use.
Area of Science:
- Cardiovascular Medicine
- Medical Device Technology
- Clinical Trials
Context:
- The intra-aortic balloon pump (IABP) has been a mainstay in cardiac procedures for over 50 years.
- It has been primarily utilized for acute myocardial infarction and cardiogenic shock.
- Recent clinical trial data has questioned its efficacy, particularly in cardiogenic shock.
Purpose:
- To critically evaluate the historical role and future of the intra-aortic balloon pump (IABP).
- To discuss the implications of recent clinical trial outcomes on IABP usage.
- To emphasize the importance of robust clinical evidence for new medical technologies.
Summary:
- The intra-aortic balloon pump (IABP), a long-standing device in cardiology and cardiothoracic surgery, faces a significant decline in clinical use.
- Its failure to demonstrate efficacy in recent cardiogenic shock trials suggests its role will become extremely limited.
- The experience with IABP highlights the need to avoid reliance on surrogate endpoints and prioritize randomized controlled trials.
Impact:
- This analysis signals a potential paradigm shift in mechanical circulatory support for acute cardiac conditions.
- It underscores the critical need for evidence-based medicine and rigorous evaluation of medical devices.
- Future development and adoption of cardiac support technologies must be guided by high-quality clinical evidence from randomized controlled trials.
